| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,481,000 | 3,810,200 | 3,611,600 | 3,324,200 | | Cost of Revenue | 2,442,000 | 2,616,800 | 2,511,600 | 2,342,700 | | | Gross Profit | 1,039,000 | 1,193,400 | 1,100,000 | 981,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 319,000 | 326,400 | 326,100 | 273,400 | | Non Recurring |
-
|
-
| (16,400) | 16,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 720,000 | 867,000 | 790,300 | 691,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (34,000) | 18,800 | 24,800 | (4,100) | | Earnings Before Interest And Taxes | 714,000 | 891,000 | 835,200 | 704,700 | | Interest Expense | 13,000 | 14,500 | 18,600 | 24,200 | | Income Before Tax | 701,000 | 876,500 | 816,600 | 680,500 | | Income Tax Expense | 228,000 | 286,100 | 263,700 | 254,900 | | Minority Interest |
-
| (5,400) | (5,200) | (3,900) | | | | Net Income From Continuing Ops | 473,000 | 585,000 | 547,700 | 421,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 473,000 | 585,000 | 547,700 | 421,700 | | Preferred Stock And Other Adjustments | (3,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $470,000 | $585,000 | $547,700 | $421,700 |
|
0.45% Nasdaq 
0.20%
Income Statement
